Table 1

- Baseline characteristics for the studied cohort according to gender and type of surgery.

VariablesTotal (232)GenderP-value*SurgeryP-value
Male (44%)Female (56%)LSG sleeve (93.4%)RYGB bypass (6.6%)
Age (years), n (%)
mean (± standard deviation [SD])44.3 ± 10.342.8 ± 10.545.5 ± 9.90.04543.8 ± 10.152.1 ± 12.00.002
< 34 years,38(16.4)24 (23.5)14 (10.8)0.05437 (17.5)1 (6.7)0.002
34- 44 years93(40.1)40 (39.2)53 (40.8)87 (41.0)2 (13.3)
45- 54 years59(25.4)21 (20.6)38 (29.2)54(25.5)4 (26.7)
>54 years42(18.1)17 (16.7)25 (19.2)34 (16.0)8 (53.3)
Education level, n (%)
Post graduate10 (4.58)6 (6.31)4 (3.25)0.0006 (3.0)4 (22.22)0.379
University84 (38.53)51 (53.68)33 (26.82)80 (40.0)4 (22.22)
High school72 (33.02)30 (31.57)42 (34.14)66 (33.0)6 (33.33)
<High school38 (17.43)8 (8.42)30 (24.39)36 (18.0)2 (11.11)
Illiterate14 (6.42)0 (0.0)14 (11.38)12 (6.0)2 (11.11)
Income (Saudi Riyals), n (%)
<5,000 SR, --31(14.2)9 (9.5)22 (17.9)0.00430 (15.0)1 (7.1)0.513
5,000-10,000 SR86(39.4)30 (31.6)56 (45.5)80 (40.0)6 (42.9)
>10,000 SR101(46.3)56 (58.9)45 (36.6)90 (45.0)7 (50.0)
Smoking status, n (%)
Current28 (12.8)24 (25.0)4 (3.3)0.00027 (13.4)0 (0.0)0.051
Ex-smoker21 (9.6)20 (20.8)1 (0.8)21 (10.4)0 (0.0)
None170 (77.6)52 (54.2)118 (95.9)153 (76.1)14 (100)
Physical activity, n (%)
≥150 min/week99 (45.4)50 (50.5)49 (49.5)0.17293 (95.9)4 (4.1)0.193
Body mass index, n (%)
mean (± SD)45±6.7544.90±6.7045.51 ± 6.820.49545.31 ± 6.7044.4 ± 7.650.616
< 35 kg/m27 (3.0)4 (3.9)3 (2.3)0.0006 (2.8)1 (6.7)0.615
36-40 kg/m242 (18.2)16 (15.7)26 (20.2)35 (16.6)5 (33.3)
> 40 kg/m2182 (78.8)82 (80.4)100 (77.5)170 (80.6)9 (60.0)
Diabetes mellitus duration
mean (± SD)8 ± 78 ± 89 ± 70.5018 ± 715 ± 110.001
<5 years99 (48.1)50 (55.9)49 (42.2)0.30793 (49.5)4 (28.6)0.024
6 -10 years53 (25.7)20 (22.2)33 (28.4)50 (26.6)2 (14.3)
>10 years54 (26.2)20 (22.2)34 (29.3)45 (23.9)8 (57.1)
Diabetes mellitus complication
Neuropathy50 (49.01)20 (51.28)30 (47.61)0.32646 (51.11)4 (36.36)0.46
Retinopathy47 (46.07)17 (43.58)30 (47.61)0.26740 (44.44)6 (54.54)0.068
Vasculopathy3 (2.94)1 (2.56)2 (3.17)0.6033 (3.33)0 (0.0)0.807
Nephropathy2 (1.96)1 (2.56)1 (1.58)0.8521 (1.11)1 (9.09)0.826
Comorbidity
Hypertension111 (48.3)50 (45.0)61 (55.0)0.459100 (90.1)11 (9.9)0.046
Hyperlipidemia104 (45.2)42 (40.4)62 (59.6)0.15289 (87.3)13 (12.7)0.001
Hyperthyroidism34 (15.0)9 (26.5)25 (73.5)0.00530 (88.2)4 (11.8)0.93
Metabolic markers
Hemoglobin A1c (%)8.04 ± 1.598.42 ± 1.778.22 ± 1.670.1008.93 ± 2.048.04 ± 1.590.121
Fasting blood sugar (mmol/L)8.25 ± 1.708.99 ± 3.679.01 ± 3.320.9629.08 ± 3.448.47 ± 3.950.528
High density lipoprotein (mmol/L)9.00 ± 3.461.27 ± 0.771.23 ± 0.400.6601.23 ± 0.521.42 ± 0.860.228
Low density lipoprotein (mmol/L)1.24 ± 0.562.54 ± 0.762.83 ± 0.970.0642.76 ± 0.902.42 ± 0.850.157
Ttriglycerides (mmol/L)2.73 ± 0.911.68 ± 0.911.62 ± 0.900.6861.63 ± 0.931.68 ± 0.610.850
Total cholesterol (mmol/L)1.64 ± 0.904.04 ± 1.194.56 ± 1.280.0164.37 ± 1.294.28 ± 1.080.784
Renal functions
Serum creatinine,(µmol/L)4.36 ± 1.2771.46 ± 21.7459.14 ± 26.680.0064.25 ± 26.1365.36 ± 14.650.875
Blood urea nitrogen, (mg/dl)64.39 ± 25.385.73 ± 3.824.96 ± 5.280.3485.37 ± 5.003.96 ± 1.350.316
Thyroid functions
Thyroid stimulating hormone (mIU/L)5.25 ± 4.782.44 ± 1.752.58 ± 1.650.6102.46 ± 1.612.97 ± 2.550.366
Free thyroxin t4 test (pmol/L)2.52 ± 1.6912.62 ± 5.7314.41 ± 4.710.06314.06 ± 5.0114.49 ± 2.110.780
  • LSG: laparoscopic sleeve gastrectomy, RYGB: Roux-en-y gastric bypass.

  • * P-value comparing males to females,

  • P-value comparing LSG to RYGB surgery